Volume 6, Issue 4 (11-2024)
Tabari Biomed Stu Res J 2024, 6(4): 29-35 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Izadpanah M, Adebomojo O. The possible involvement of miR-34 in cancer treatment. Tabari Biomed Stu Res J 2024; 6 (4) :29-35
URL: http://tbsrj.mazums.ac.ir/article-1-3853-en.html
URL: http://tbsrj.mazums.ac.ir/article-1-3853-en.html
1- tabriz university of medical sciences
2- Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA. 2. Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, IN, USA.
2- Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA. 2. Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, IN, USA.
Abstract:
Cancer is one of the major causes of morbidity and mortality worldwide, resulting from complex interactions between genetic, epigenetic and environmental factors. In the present study, the multifaceted nature of cancer, epidemiology, pathogenesis, and the complex role of genes and microRNAs in the development and progression of tumors have been investigated. We delved into the importance of oncogenes and tumor suppressor genes, especially the pivotal role of the p53 gene in cell cycle regulation and DNA repair mechanisms. In addition, in the current study, the therapeutic potential of microRNAs, especially miR-34, in overcoming chemotherapy resistance and Increasing the effectiveness of treatment has been discussed. By understanding these underlying mechanisms, we aim to provide insight into innovative cancer prevention and treatment strategies.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
